Showing results (121-130 of 179) with videos related to
Sort By:
Pageof 18
Oncology|September 1, 1995
Prognostic value of CD44 splice variant expression in ovarian cancerM Uhl-Steidl, E Müller-Holzner, A G Zeimet, et al.Cancer|May 15, 1993
In vitro and in vivo evaluation of the combination of cisplatin and its analogue carboplatin for platinum dose intensification in ovarian carcinomaC Dittrich, P Sevelda, M Baur, et al.Cancer|January 28, 1999
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant diseaseA Kraft, K Weindel, A Ochs, et al.Anesthesia and Analgesia|August 29, 2001
The influence of atracurium, cisatracurium, and mivacurium on the proliferation of two human cell lines in vitroA Amann, J Rieder, M Fleischer, et al.Cancer Research|October 23, 1997
Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal breast tissue distant from the cancerM Widschwendter, J Berger, G Daxenbichler, et al.International Journal of Cancer|December 15, 1994
Effects of type-I and -II interferons on 90K antigen expression in ovarian carcinoma cellsC Marth, A Dreps, C Natoli, et al.International Journal of Cancer|September 27, 1996
Circulating immunostimulatory protein 90K and soluble interleukin-2-receptor in human ovarian cancerA G Zeimet, C Natoli, M Herold, et al.International Journal of Cancer|July 1, 1994
Increased production of immune activation marker neopterin by colony-stimulating factors in gynecological cancer patientsC Marth, G Weiss, A Koza, et al.Cancer Research|September 1, 1997
Paclitaxel- and docetaxel-dependent activation of CA-125 expression in human ovarian carcinoma cellsC Marth, A G Zeimet, M Widschwendter, et al.British Journal of Cancer|November 13, 2003
MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor statusH M Müller, H Fiegl, G Goebel, et al.Pageof 18